COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 583: Articles 5821-5830  | Next

SARS-CoV-2 immune complex triggers human monocyte necroptosis
Santos, L., Antunes, K. H., Cassao, G., Goncalves, J. I., Abbadi, B. L., Bizarro, C. V., Basso, L. A., Machado, P., Souza, A. P. D. d., Porto, B.
10.1101/2022.10.13.512127 — Posted: 2022-10-14
Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants
Bendall, E. E., Callear, A., Getz, A., Goforth, K., Edwards, D., Monto, A., Martin, E. T., Lauring, A. S.
10.1101/2022.10.12.511991 — Posted: 2022-10-14
Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1Omicron
Chen, D.-Y., Kenney, D., Chin, C.-V., Tavares, A. H., Khan, N., Conway, H. L., Liu, G., Choudhary, M. C., Gertje, H. P., OConnell, A. K., Kotton, D. N., Herrmann, A., Ensser, A., Connor, J. H., Bosmann, M., Li, J. Z., Gack, M. U., Baker, S. C., Kirchdoerfer, R. N., Kataria, Y., Crossland, N. A., Douam, F., Saeed, M.
10.1101/2022.10.13.512134 — Posted: 2022-10-14
Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly.
Ferreira, I. A. T. M., Lee, C. Y. C., Foster, W., Abdullahi, A., Tuong, Z. K., Stewart, B. J., Ferdinand, J. R., Guillaume, S., Potts, M. O. P., Perera, M., Krishna, B. A., Alonso, A. P., Cabantous, M., Kemp, S. A., Ceron-Gutierrez, L., Ebrahimi, S., The CITIID- NIHR BioResource COVID-19 Collaboration, , Lyons, P., Smith, K. G. C., Bradley, J., Collier, D. A., Teichmann, S. A., McCoy, L. E., MacAry, P. A., Doffinger, R., Wills, M. R., Linterman, M., Clatworthy, M. R., Gupta, R. K.
10.1101/2022.10.13.22281024 — Posted: 2022-10-13
Understanding mental health trends during COVID-19 pandemic in the United States using network analysis
Kobayashi, H., Saenz-Escarcega, R., Fulk, A., Agusto, F.
10.1101/2022.10.10.22280933 — Posted: 2022-10-13
Risk of Myocarditis and Pericarditis Following Coronavirus Disease 2019 Messenger RNA Vaccination - A Nationwide Study
Su, W.-J., Liu, Y.-L., Chang, C.-H., Lin, Y.-C., Huang, W.-I., Wu, L.-C., Chen, S.-F., Lin, Y.-S., Hsieh, Y.-L., Yang, C.-A., Lin, C.-H., Chan, K.-W. A., Lee, P.-I., Chuang, J.-H., Yang, C.-H.
10.1101/2022.10.11.22280860 — Posted: 2022-10-13
Increased levels of inflammatory molecules in blood of Long COVID patients point to thrombotic endotheliitis
Turner, S., Naidoo, C., Usher, T., Kruger, A., Venter, C., Laubscher, G. J., Khan, M. A., Kell, D. B., Pretorius, E.
10.1101/2022.10.13.22281055 — Posted: 2022-10-13
Identifying Contextual and Spatial Risk Factors for Post-Acute Sequelae of SARS-CoV-2 Infection: An EHR-based Cohort Study from the RECOVER Program
Zhang, Y., Hu, H., Fokaidis, V., Lewis, C., Xu, J., Zang, C., Xu, Z., Wang, F., Koropsak, M., Bian, J., Hall, J., Rothman, R., Shenkman, E., Wei, W.-Q., Weiner, M. G., Carton, T. W., Kaushal, R.
10.1101/2022.10.13.22281010 — Posted: 2022-10-13
Residential clustering of COVID-19 cases and efficiency of building-wide compulsory testing notices as a transmission control measure in Hong Kong
Young, B., Yang, B., Wu, P., Adam, D., Wong, J., Ho, F., Gao, H., Leung, G., Cowling, B. J.
10.1101/2022.10.12.22280904 — Posted: 2022-10-13
Laboratory evaluation of a quaternary ammonium compound (QAC)-based antimicrobial coating used in public transport during the COVID-19 pandemic
Aranega-Bou, P., Brown, N., Stigling, A., D'Costa, W., Verlander, N. Q., Pottage, T., Bennett, A., Moore, G.
10.1101/2022.10.12.512011 — Posted: 2022-10-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).